Imam Abdulrahman Bin Faisal University, formerly known as the University of Dammam, is a university in Dammam, Saudi Arabia. It is one of the oldest universities in the Eastern Province of Saudi Arabia. It is one of the leading universities in medicine for both male and female students.

During the past decade, Imam Abdulrahman Bin Faisal University conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Imam Abdulrahman Bin Faisal University" #1 sponsor was "Imam Abdulrahman Bin Faisal University" with 23 trials, followed by "Khalood Saeed Bahammam" with 1 trials sponsored, "King Fahad Specialist Hospital Dammam" with 1 trials sponsored, "McMaster University" with 1 trials sponsored and "University College, London" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Imam Abdulrahman Bin Faisal University" #1 collaborator was "Qatif Central Hospital" with 2 trials as a collaborator, "Dammam Medical Complex" with 1 trials as a collaborator, "Institute for Research and medical consultations (IRMC)" with 1 trials as a collaborator, "John Hopkins Aramco Healthcare" with 1 trials as a collaborator and "Johns Hopkins Aramco Healthcare" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Imam Abdulrahman Bin Faisal University" are "Cardiac Surgery" (2 trials), "Anterior Cruciate Ligament" (1 trials), "Bone Density Increased" (1 trials), "Bone Density, Low" (1 trials) and "Cardiopulmonary Bypass" (1 trials). Many other conditions were trialed in "Imam Abdulrahman Bin Faisal University" in a lesser frequency.

Most popular intervention types in "Imam Abdulrahman Bin Faisal University" are "Other" (12 trials), "Device" (7 trials), "Drug" (7 trials), "Behavioral" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AirTraq" (1 trials), "Arndt® blocker" (1 trials), "Boost to the tumour bed" (1 trials) and "Bronchial Suction group" (1 trials). Other intervention names were less common.

The vast majority of trials in "Imam Abdulrahman Bin Faisal University" are 22 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Imam Abdulrahman Bin Faisal University". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Imam Abdulrahman Bin Faisal University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Imam Abdulrahman Bin Faisal University, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 15 trials that are defined as “Not Applicable".

Imam Abdulrahman Bin Faisal University has several departments that took part in Clinical trials: "College of Clinical Pharmacy" - 2 trials